<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02189473</url>
  </required_header>
  <id_info>
    <org_study_id>ARO 200901</org_study_id>
    <nct_id>NCT02189473</nct_id>
  </id_info>
  <brief_title>Radiotherapy of Motor Deficits From Metastatic Epidural Spinal Cord Compression</brief_title>
  <acronym>SCORE-2</acronym>
  <official_title>Radiotherapy of Motor Deficits From Metastatic Epidural Spinal Cord Compression (10 x 3 Gy Versus 5 x 4 Gy)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof. Dirk Rades, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Schleswig-Holstein</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this randomized multi-center trial is to investigate the efficacy of the
      radiotherapy regimens 5 x 4 Gy and 10 x 3 Gy with respect to the effect on motor function in
      patients with metastatic epidural spinal cord compression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim of this randomized multi-center trial is to investigate the efficacy of the
      radiotherapy regimens 5 x 4 Gy and 10 x 3 Gy with respect to the effect on motor function in
      patients with metastatic epidural spinal cord compression. The response rate (improvement in
      motor function or prevention of progression) will be assessed at one month following
      radiotherapy.

      In addition, the following endpoints will be evaluated:

        1. Motor function; additional assessments directly and at 3 and at 6 months after
           radiotherapy

        2. Ability to walk; assessment directly and at 1, 3 and 6 months after radiotherapy

        3. Sensory function; assessment directly and at 1, 3 and 6 months after radiotherapy

        4. Quality of life; evaluation directly and at 1, 3 and 6 months after radiotherapy

        5. Pain assessment directly and at 1, 3 and 6 months after radiotherapy

        6. Overall survival up to 6 months following radiotherapy

        7. Local Progression-free survival up to 6 months following radiotherapy
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Motor function</measure>
    <time_frame>at 1 month following radiotherapy</time_frame>
    <description>effect of radiotherapy on motor function (improvement, no further progression, deterioration) 0 = Complete paraplegia
= Palpable or visible muscle contractions
= Active movement, without gravity
= Active movement, against gravity
= Active movement, against mild resistance
= Active movement, against intermediate resistance
= Active movement, against strong resistance
= Normal strength</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ability to walk</measure>
    <time_frame>directly, at 1 month, at 3 months and at 6 months following radiotherapy</time_frame>
    <description>0 = Normal strength
= Ambulatory without aid
= Ambulatory with aid
= Not ambulatory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local Progression Free Survival</measure>
    <time_frame>up to 6 months following radiotherapy</time_frame>
    <description>freedom from progression of motor deficits during or one month following RT and freedom from in-field recurrence of MSCC during follow up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>directly, at 1 month, at 3 months and at 6 months following radiotherapy</time_frame>
    <description>distress thermometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>directly, at 1 month, at 3 months and at 6 months following radiotherapy</time_frame>
    <description>numeric rating scale from 0-10 (self assessment: from 0 = no pain; 1 = mild pain to 10 = very severe pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>up to 6 months following radiotherapy</time_frame>
    <description>Kaplan-Meier method, log rank test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor function</measure>
    <time_frame>directly, at 3 months and at 6 months following radiotherapy</time_frame>
    <description>effect of radiotherapy on motor function (improvement, no further progression, deterioration) 0 = Complete paraplegia
= Palpable or visible muscle contractions
= Active movement, without gravity
= Active movement, against gravity
= Active movement, against mild resistance
= Active movement, against intermediate resistance
= Active movement, against strong resistance
= Normal strength</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Toxicity</measure>
    <time_frame>during radiotherapy and directly, at 1 month, at 3 months and at 6 months following radiotherapy</time_frame>
    <description>common terminology criteria for adverse events (CTCAE 3.0)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">203</enrollment>
  <condition>Metastatic Epidural Spinal Cord Compression</condition>
  <arm_group>
    <arm_group_label>5 x 4 Gy in 1 week</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>radiotherapy with 5 x 4 Gy in 1 week (5 x 4 Gy per week)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 x 3 Gy in 2 weeks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>radiotherapy with 10 x 3 Gy in 2 weeks (5 x 3 Gy per week)</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiotherapy</intervention_name>
    <description>external beam radiotherapy (5 x 4 Gy versus 10 x 3 Gy)</description>
    <arm_group_label>5 x 4 Gy in 1 week</arm_group_label>
    <arm_group_label>10 x 3 Gy in 2 weeks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Motor deficits of the lower extremities resulting from metastatic epidural spinal cord
             compression, which have persisted for no longer than 30 days

          -  Confirmation of diagnosis by magnetic resonance imaging (spinal computed tomography
             allowed)

          -  Relatively poor survival prognosis (defined as ≤35 points on the survival score
             published in Cancer 2008)

          -  Written informed consent

        Exclusion Criteria:

          -  Prior radiotherapy or surgery of the spinal areas affected by MESCC

          -  History of symptomatic brain tumor or symptomatic brain metastases

          -  Metastases of the cervical spine only

          -  Other severe neurological disorders

          -  Pregnancy, Lactation

          -  Indication for decompressive surgery + stabilization of the affected spinal areas
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dirk Rades, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Radiation Oncology, University of Lübeck, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oberschwabenklinik Ravensburg</name>
      <address>
        <city>Ravensburg</city>
        <state>Baden-Wutemberg</state>
        <zip>88191</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Bayreuth</name>
      <address>
        <city>Bayreuth</city>
        <state>Bavaria</state>
        <zip>95445</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Regensburg</name>
      <address>
        <city>Regensburg</city>
        <state>Bavaria</state>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Würzburg</name>
      <address>
        <city>Würzburg</city>
        <state>Bavaria</state>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ruhr University</name>
      <address>
        <city>Bochum</city>
        <state>North Rhine Westphalia</state>
        <zip>44801</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiotherapy Practice Dresden-Friedrichstadt</name>
      <address>
        <city>Dresden</city>
        <state>Saxonia</state>
        <zip>01067</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Lübeck</name>
      <address>
        <city>Lübeck</city>
        <state>Schleswig-Holstein</state>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center of Radiotherapy and Radiation Oncology</name>
      <address>
        <city>Bremen</city>
        <zip>28239</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Oncology, Vilnius University</name>
      <address>
        <city>Vilnius</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saad Specialist Hospital</name>
      <address>
        <city>Al Khobar</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Oncology</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Consorcio Hospitalario Provencial de Castellon</name>
      <address>
        <city>Valencia</city>
        <state>Castellon</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cruces University Hospital</name>
      <address>
        <city>Barakaldo</city>
        <state>Vizcaya (Basque Country)</state>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Lithuania</country>
    <country>Saudi Arabia</country>
    <country>Slovenia</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Maranzano E, Latini P. Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):959-67.</citation>
    <PMID>7607970</PMID>
  </reference>
  <reference>
    <citation>Sørensen S, Børgesen SE, Rohde K, Rasmusson B, Bach F, Bøge-Rasmussen T, Stjernholm P, Larsen BH, Agerlin N, Gjerris F, et al. Metastatic epidural spinal cord compression. Results of treatment and survival. Cancer. 1990 Apr 1;65(7):1502-8.</citation>
    <PMID>2311062</PMID>
  </reference>
  <reference>
    <citation>Helweg-Larsen S, Sørensen PS, Kreiner S. Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1163-9.</citation>
    <PMID>10725627</PMID>
  </reference>
  <reference>
    <citation>Leviov M, Dale J, Stein M, Ben-Shahar M, Ben-Arush M, Milstein D, Goldsher D, Kuten A. The management of metastatic spinal cord compression: a radiotherapeutic success ceiling. Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):231-4.</citation>
    <PMID>8407396</PMID>
  </reference>
  <reference>
    <citation>Rades D, Blach M, Bremer M, Wildfang I, Karstens JH, Heidenreich F. Prognostic significance of the time of developing motor deficits before radiation therapy in metastatic spinal cord compression: one-year results of a prospective trial. Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1403-8.</citation>
    <PMID>11121640</PMID>
  </reference>
  <reference>
    <citation>Rades D, Heidenreich F, Bremer M, Karstens JH. Time of developing motor deficits before radiotherapy as a new and relevant prognostic factor in metastatic spinal cord compression: final results of a retrospective analysis. Eur Neurol. 2001;45(4):266-9.</citation>
    <PMID>11385267</PMID>
  </reference>
  <reference>
    <citation>Rades D, Heidenreich F, Karstens JH. Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression. Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):975-9.</citation>
    <PMID>12095565</PMID>
  </reference>
  <reference>
    <citation>Arcangeli G, Giovinazzo G, Saracino B, D'Angelo L, Giannarelli D, Arcangeli G, Micheli A. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):1119-26.</citation>
    <PMID>9869238</PMID>
  </reference>
  <reference>
    <citation>Niewald M, Tkocz HJ, Abel U, Scheib T, Walter K, Nieder C, Schnabel K, Berberich W, Kubale R, Fuchs M. Rapid course radiation therapy vs. more standard treatment: a randomized trial for bone metastases. Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1085-9.</citation>
    <PMID>8985030</PMID>
  </reference>
  <reference>
    <citation>8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol. 1999 Aug;52(2):111-21.</citation>
    <PMID>10577696</PMID>
  </reference>
  <reference>
    <citation>Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, de Haes H, Martijn H, Oei B, Vonk E, van der Steen-Banasik E, Wiggenraad RG, Hoogenhout J, Wárlám-Rodenhuis C, van Tienhoven G, Wanders R, Pomp J, van Reijn M, van Mierlo I, Rutten E. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol. 1999 Aug;52(2):101-9. Erratum in: Radiother Oncol 1999 Nov;53(2):167. Leer, J [corrected to Leer, JW]; van Mierlo ,T [corrected to van Mierlo, I].</citation>
    <PMID>10577695</PMID>
  </reference>
  <reference>
    <citation>Rades D, Stalpers LJ, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC, Poortmans P, Schild SE. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol. 2005 May 20;23(15):3366-75.</citation>
    <PMID>15908648</PMID>
  </reference>
  <reference>
    <citation>Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22. Review.</citation>
    <PMID>2032882</PMID>
  </reference>
  <reference>
    <citation>Barendsen GW. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 1982 Nov;8(11):1981-97. Review.</citation>
    <PMID>6759484</PMID>
  </reference>
  <reference>
    <citation>Koswig S, Budach V. [Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study]. Strahlenther Onkol. 1999 Oct;175(10):500-8. German.</citation>
    <PMID>10554645</PMID>
  </reference>
  <reference>
    <citation>Rades D, Dunst J, Schild SE. The first score predicting overall survival in patients with metastatic spinal cord compression. Cancer. 2008 Jan 1;112(1):157-61.</citation>
    <PMID>17948910</PMID>
  </reference>
  <reference>
    <citation>Tomita T, Galicich JH, Sundaresan N. Radiation therapy for spinal epidural metastases with complete block. Acta Radiol Oncol. 1983;22(2):135-43.</citation>
    <PMID>6310968</PMID>
  </reference>
  <reference>
    <citation>Maranzano E, Bellavita R, Rossi R, De Angelis V, Frattegiani A, Bagnoli R, Mignogna M, Beneventi S, Lupattelli M, Ponticelli P, Biti GP, Latini P. Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol. 2005 May 20;23(15):3358-65. Epub 2005 Feb 28.</citation>
    <PMID>15738534</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2014</study_first_submitted>
  <study_first_submitted_qc>July 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2014</study_first_posted>
  <last_update_submitted>August 4, 2017</last_update_submitted>
  <last_update_submitted_qc>August 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Schleswig-Holstein</investigator_affiliation>
    <investigator_full_name>Prof. Dirk Rades, MD</investigator_full_name>
    <investigator_title>Prof. Dr. Dirk Rades. MD</investigator_title>
  </responsible_party>
  <keyword>metastatic epidural spinal cord compression</keyword>
  <keyword>motor function</keyword>
  <keyword>ambulatory status</keyword>
  <keyword>pain</keyword>
  <keyword>quality of life</keyword>
  <keyword>overall survival</keyword>
  <keyword>local control</keyword>
  <keyword>toxicity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Compression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

